Tue, Feb 9, 2016
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Private Equity Strategies

Editorial

Saturday, June 22, 2013

Welcome to the June issue of Private Equity Strategies. This issue we will be featuring some new market sector coverage along with a few recent updates from stories we’ve covered before.

In a new feature - MicroCap Monitor we are looking at DelMar Pharmaceuticals, which has been making the rounds following a recent IPO. The company is gaining the attention of both private equity and alternatives investors based on recent cancer treatment trials in the US and abroad.

In our Dealmakers Q&A we speak with StoneCapital Partners to learn about community bank investing, which may be some of the cleanest assets available in the market today. An update from the Russian Direct Investment Fund features a new fund launched with the Abu Dabi Investment Company along with new interest in infrastructure.

In Regs watch we bring new you changes in regulation that may have a significant impact for private equity firms.

In Movers and Shakers Evercore Partners raises its largest fund to date for investements in Mexico. And in The Next Generation we highlight a bit of a row happening in the UK between the British Venture Capital Association and local business schools on the impact of PE investments on employment.

As always in Quick Hits we bring you the latest fund news and events. I welcome your feedback and hope you enjoy the issue and the summer season. Please send me any updates, thoughts, tips or comments.

Best,

Bailey McCann

Editor

 
This article was published in Opalesque's Private Equity Strategies our monthly research update on the global private equity landscape including all sectors and market caps.
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies


Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Avenue Capital's Marc Lasry: We like European bank loans, Comment: A bunch of hedge fund managers are chasing the 'dream of crushing a major structural problem'[more]

    Avenue Capital's Marc Lasry: We like European bank loans From CNBC.com: European banks are under immense pressure, but at least one prominent hedge fund has found what it thinks is a good opportunity in the wreckage. Marc Lasry, co-founder and chief executive of hedge fund Avenue Capital

  2. Credit Suisse cherry picks hedge fund ideas[more]

    From FT.com: Credit Suisse Asset Management plans to cherry pick profitable concepts from hedge funds with the launch in Europe of a “best ideas” strategy. The investment arm of the Swiss bank said the strategy will separate it from other funds blighted by “overcrowding problems”. It comes at a time

  3. Investing - Hedge funds bet on risks in U.S. blue-chip debt, Hedge funds bets against bank credit risk paying off, Tiger Global still likes Internet names, gets pointers from Jeter[more]

    Hedge funds bet on risks in U.S. blue-chip debt From WSJ.com: Hedge funds are betting the next bond sector to crack will be the $4.5 trillion market for the safest U.S. corporate debt. New York’s Perry Capital has placed a $1 billion wager against investment-grade bonds issued by 10 comp

  4. Short Selling - Hedge fund manager Kyle Bass is shorting real estate—again, Top US hedge fund has €80m short position in Paddy Power Betfair[more]

    Hedge fund manager Kyle Bass is shorting real estate—again From Fortune.com: He also predicted the mortgage crisis in 2008. Hedge fund manager Kyle Bass, who runs Dallas-based Hayman Capital, tanked the stock of a little-known real estate financier Friday by revealing that he is shorting

  5. HFRU Hedge Fund Composite Index down -2.58% in January[more]

    Global financial markets posted sharp losses in January led by declines in Oil and global equities, though steep intra-month losses in both were narrowed by strong gains in final trading days of the month. Global equities posted steep declines for the month led by Biotechnology, Energy, Financial, E